Claim: Are private AI companies collecting a 20% bonus for every Medicare patient claim they reject?

The claim that private AI companies collect a 20% bonus for every Medicare patient claim they reject is mostly false. Reports indicate that while AI companies may be rewarded for savings from denied claims, officials assert that they are prohibited from receiving compensation directly tied to denial rates. This suggests that the incentive structure is more complex than a straightforward bonus for rejections. Some sources support the idea of incentives for savings, but they dispute the notion of a direct bonus for denials, emphasizing safeguards against denying appropriate care. Overall, the evidence does not support the claim as stated. The models diverge sharply — treat this as higher-uncertainty. Perplexity comes in highest (85%), while OpenAI is lowest (40%). Perplexity expresses higher confidence than Gemini on this claim. While some sources suggest that AI companies are incentivized to deny claims by receiving a share of the savings from averted care, they also highlight that officials have implemented safeguards to prevent direct bonuses tied to denial rates. This creates uncertainty around the claim, as it implies a direct financial incentive for rejecting claims, which is contested by officials who emphasize the importance of maintaining appropriate care standards. Therefore, while there may be incentives related to savings, the specific claim of a 20% bonus for every rejection lacks sufficient support and clarity.